Loading...
Header Logo
Keywords
Last Name
Institution

JAMES BYRD

TitleAssociate Professor
InstitutionMD Anderson
DepartmentGastroenterology Hepatology & Nutrition
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Nadar SK, Tayebjee MH, Stowasser M, Byrd JB. Managing hypertension during the COVID-19 pandemic. J Hum Hypertens. 2020 May 14. PMID: 32409727.
      View in: PubMed
    2. Byrd JB, Bello N, Meyer MN. Pandemic Pandemonium: Pausing Clinical Research During the COVID-19 Outbreak. Circulation. 2020 Apr 22. PMID: 32320272.
      View in: PubMed
    3. Sparks MA, South A, Welling P, Luther JM, Cohen J, Byrd JB, Burrell LM, Batlle D, Tomlinson L, Bhalla V, Rheault MN, Soler MJ, Swaminathan S, Hiremath S. Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19. Clin J Am Soc Nephrol. 2020 May 07; 15(5):714-716. PMID: 32220930.
      View in: PubMed
    4. Berrido AM, Byrd JB. Angiotensin Receptor Blockers and the Risk of Cancer: Insights from Clinical Trials and Recent Drug Recalls. Curr Hypertens Rep. 2020 Feb 29; 22(3):20. PMID: 32114653.
      View in: PubMed
    5. Dixon DL, Salgado TM, Luther JM, Byrd JB. Medicare reimbursement policy for ambulatory blood pressure monitoring: A qualitative analysis of public comments to the Centers for Medicare and Medicaid Services. J Clin Hypertens (Greenwich). 2019 12; 21(12):1803-1809. PMID: 31642596.
      View in: PubMed
    6. Gunasekaran PM, Chertow GM, Bhalla V, Byrd JB. Current Status of Angiotensin Receptor Blocker Recalls. Hypertension. 2019 12; 74(6):1275-1278. PMID: 31630573.
      View in: PubMed
    7. Byrd JB, Brook RD. Hypertension. Ann Intern Med. 2019 05 07; 170(9):ITC65-ITC80. PMID: 31060074.
      View in: PubMed
    8. Gunasekaran PM, Luther JM, Byrd JB. For what factors should we normalize urinary extracellular mRNA biomarkers? Biomol Detect Quantif. 2019 Mar; 17:100090. PMID: 31285998.
      View in: PubMed
    9. Stowasser M, Nadar SK, Byrd JB. Strengthening a societal tie and other new initiatives for 2019. J Hum Hypertens. 2019 03; 33(3):173. PMID: 30846845.
      View in: PubMed
    10. Melville S, Byrd JB. Personalized Medicine and the Treatment of Hypertension. Curr Hypertens Rep. 2019 02 12; 21(2):13. PMID: 30747306.
      View in: PubMed
    11. Nanba AT, Wannachalee T, Shields JJ, Byrd JB, Rainey WE, Auchus RJ, Turcu AF. Adrenal Vein Sampling Lateralization Despite Mineralocorticoid Receptor Antagonists Exposure in Primary Aldosteronism. J Clin Endocrinol Metab. 2019 02 01; 104(2):487-492. PMID: 30239792.
      View in: PubMed
    12. Melville S, Byrd JB. Out-of-Office Blood Pressure Monitoring in 2018. JAMA. 2018 Nov 06; 320(17):1805-1806. PMID: 30398589.
      View in: PubMed
    13. Rayyan M, Zheutlin A, Byrd JB. Clinical research using extracellular vesicles: insights from the International Society for Extracellular Vesicles 2018 Annual Meeting. J Extracell Vesicles. 2018; 7(1):1535744. PMID: 31162489.
      View in: PubMed
    14. Bazzell BG, Rainey WE, Auchus RJ, Zocco D, Bruttini M, Hummel SL, Byrd JB. Human Urinary mRNA as a Biomarker of Cardiovascular Disease. Circ Genom Precis Med. 2018 09; 11(9):e002213. PMID: 30354328.
      View in: PubMed
    15. Byrd JB, Newby DE, Anderson JA, Calverley PMA, Celli BR, Cowans NJ, Crim C, Martinez FJ, Vestbo J, Yates J, Brook RD. Blood pressure, heart rate, and mortality in chronic obstructive pulmonary disease: the SUMMIT trial. Eur Heart J. 2018 09 01; 39(33):3128-3134. PMID: 30101300.
      View in: PubMed
    16. Byrd JB, Turcu AF, Auchus RJ. Primary Aldosteronism: Practical Approach to Diagnosis and Management. Circulation. 2018 08 21; 138(8):823-835. PMID: 30359120.
      View in: PubMed
    17. Zheutlin AR, Byrd JB. Opening Opportunities With Open Data. JACC Heart Fail. 2018 06; 6(6):530-532. PMID: 29655821.
      View in: PubMed
    18. Liu X, Byrd JB, Rodriguez CJ. Use of physician-recommended non-pharmacological strategies for hypertension control among hypertensive patients. J Clin Hypertens (Greenwich). 2018 03; 20(3):518-527. PMID: 29450958.
      View in: PubMed
    19. Nanba AT, Nanba K, Byrd JB, Shields JJ, Giordano TJ, Miller BS, Rainey WE, Auchus RJ, Turcu AF. Discordance between imaging and immunohistochemistry in unilateral primary aldosteronism. Clin Endocrinol (Oxf). 2017 Dec; 87(6):665-672. PMID: 28787766.
      View in: PubMed
    20. Skolarus LE, Cowdery J, Dome M, Bailey S, Baek J, Byrd JB, Hartley SE, Valley SC, Saberi S, Wheeler NC, McDermott M, Hughes R, Shanmugasundaram K, Morgenstern LB, Brown DL. Reach Out Churches: A Community-Based Participatory Research Pilot Trial to Assess the Feasibility of a Mobile Health Technology Intervention to Reduce Blood Pressure Among African Americans. Health Promot Pract. 2018 07; 19(4):495-505. PMID: 28583024.
      View in: PubMed
    21. Liu X, Byrd JB. Cigarette Smoking and Subtypes of Uncontrolled Blood Pressure Among Diagnosed Hypertensive Patients: Paradoxical Associations and Implications. Am J Hypertens. 2017 Jun 01; 30(6):602-609. PMID: 28203691.
      View in: PubMed
    22. Straka BT, Ramirez CE, Byrd JB, Stone E, Woodard-Grice A, Nian H, Yu C, Banerji A, Brown NJ. Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema. J Allergy Clin Immunol. 2017 Jul; 140(1):242-248.e2. PMID: 27913306.
      View in: PubMed
    23. Ilmer M, Mazurek N, Byrd JC, Ramirez K, Hafley M, Alt E, Vykoukal J, Bresalier RS. Cell surface galectin-3 defines a subset of chemoresistant gastrointestinal tumor-initiating cancer cells with heightened stem cell characteristics. Cell Death Dis. 2016 08 11; 7(8):e2337. PMID: 27512958.
      View in: PubMed
    24. Byrd JB. Personalized medicine and treatment approaches in hypertension: current perspectives. Integr Blood Press Control. 2016; 9:59-67. PMID: 27103841.
      View in: PubMed
    25. Byrd JB, Auchus RJ, White PC. Aldosterone Synthase Promoter Polymorphism and Cardiovascular Phenotypes in a Large, Multiethnic Population-Based Study. J Investig Med. 2015 Oct; 63(7):862-6. PMID: 26200036.
      View in: PubMed
    26. Byrd JB, Rothberg AE, Chomic R, Burant CF, Brook RD, Auchus RJ. Serum Cortisol-to-Cortisone Ratio and Blood Pressure in Severe Obesity before and after Weight Loss. Cardiorenal Med. 2015 Dec; 6(1):1-7. PMID: 27194991.
      View in: PubMed
    27. Byrd JB. Resistance to recommending exercise in hypertension? J Hum Hypertens. 2015 Jun; 29(6):340-1. PMID: 25391761.
      View in: PubMed
    28. Byrd JB, Brook RD. Anxiety in the "age of hypertension". Curr Hypertens Rep. 2014 Oct; 16(10):486. PMID: 25164965.
      View in: PubMed
    29. Byrd JB, Maddox TM, O'Donnell CI, Grunwald GK, Bhatt DL, Tsai TT, Rumsfeld JS, Ho PM. Clopidogrel prescription filling delays and cardiovascular outcomes in a pharmacy system integrating inpatient and outpatient care: insights from the Veterans Affairs CART Program. Am Heart J. 2014 Sep; 168(3):340-5. PMID: 25173546.
      View in: PubMed
    30. Byrd JB, Bakris G, Jamerson K. The contribution of the ACCOMPLISH trial to the treatment of stage 2 hypertension. Curr Hypertens Rep. 2014 Mar; 16(3):419. PMID: 24474031.
      View in: PubMed
    31. Byrd JB, Brook RD. Arm position during ambulatory blood pressure monitoring: a review of the evidence and clinical guidelines. J Clin Hypertens (Greenwich). 2014 Mar; 16(3):225-30. PMID: 24467382.
      View in: PubMed
    32. Pare G, Kubo M, Byrd JB, McCarty CA, Woodard-Grice A, Teo KK, Anand SS, Zuvich RL, Bradford Y, Ross S, Nakamura Y, Ritchie M, Brown NJ. Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema. Pharmacogenet Genomics. 2013 Sep; 23(9):470-8. PMID: 23838604.
      View in: PubMed
    33. Straka B, Nian H, Sloan C, Byrd JB, Woodard-Grice A, Yu C, Stone E, Steven G, Hartert T, Teo KK, Pare G, McCarty CA, Brown NJ. Pollen count and presentation of angiotensin-converting enzyme inhibitor-associated angioedema. J Allergy Clin Immunol Pract. 2013 Sep-Oct; 1(5):468-73.e1-4. PMID: 24565618.
      View in: PubMed
    34. Byrd JB, Brook RD. A critical review of the evidence supporting aldosterone in the etiology and its blockade in the treatment of obesity-associated hypertension. J Hum Hypertens. 2014 Jan; 28(1):3-9. PMID: 23698003.
      View in: PubMed
    35. Byrd JB, Vigen R, Plomondon ME, Rumsfeld JS, Box TL, Fihn SD, Maddox TM. Data quality of an electronic health record tool to support VA cardiac catheterization laboratory quality improvement: the VA Clinical Assessment, Reporting, and Tracking System for Cath Labs (CART) program. Am Heart J. 2013 Mar; 165(3):434-40. PMID: 23453115.
      View in: PubMed
    36. Byrd JB, Powers JD, Magid DJ, Tavel HM, Schmittdiel JA, O'Connor PJ, Beck AL, Butler MG, Ho PJ. Detection and recognition of hypertension in anxious and depressed patients. J Hypertens. 2012 Dec; 30(12):2293-8. PMID: 23032145.
      View in: PubMed
    37. Krantz MJ, Byrd JB. Pericardial effusion in renal disease: to tap or not to tap. Cardiology. 2011; 120(4):204-8. PMID: 22286154.
      View in: PubMed
    38. Mazurek N, Byrd JC, Sun Y, Hafley M, Ramirez K, Burks J, Bresalier RS. Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells. Cell Death Differ. 2012 Mar; 19(3):523-33. PMID: 21941373.
      View in: PubMed
    39. Byrd JB, Ho PM. The possibility of unmeasured confounding variables in observational studies: a forgotten fact? Heart. 2011 Nov; 97(22):1815-6. PMID: 21795300.
      View in: PubMed
    40. Byrd JB, Zeng C, Tavel HM, Magid DJ, O'Connor PJ, Margolis KL, Selby JV, Ho PM. Combination therapy as initial treatment for newly diagnosed hypertension. Am Heart J. 2011 Aug; 162(2):340-6. PMID: 21835296.
      View in: PubMed
    41. Mazurek N, Byrd JC, Sun Y, Ueno S, Bresalier RS. A galectin-3 sequence polymorphism confers TRAIL sensitivity to human breast cancer cells. Cancer. 2011 Oct 01; 117(19):4375-80. PMID: 21446041.
      View in: PubMed
    42. Song S, Byrd JC, Guha S, Liu KF, Koul D, Bresalier RS. Induction of MUC5AC mucin by conjugated bile acids in the esophagus involves the phosphatidylinositol 3-kinase/protein kinase C/activator protein-1 pathway. Cancer. 2011 Jun 01; 117(11):2386-97. PMID: 24048786.
      View in: PubMed
    43. Byrd JB, Woodard-Grice A, Stone E, Lucisano A, Schaefer H, Yu C, Eyler AE, Salloum NE, Brown NJ. Association of angiotensin-converting enzyme inhibitor-associated angioedema with transplant and immunosuppressant use. Allergy. 2010 Nov; 65(11):1381-7. PMID: 20557296.
      View in: PubMed
    44. Woodard-Grice AV, Lucisano AC, Byrd JB, Stone ER, Simmons WH, Brown NJ. Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema. Pharmacogenet Genomics. 2010 Sep; 20(9):532-6. PMID: 20625347.
      View in: PubMed
    45. Van Guilder GP, Pretorius M, Luther JM, Byrd JB, Hill K, Gainer JV, Brown NJ. Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition. Hypertension. 2008 Feb; 51(2):454-9. PMID: 18180402.
      View in: PubMed
    46. Byrd JB, Touzin K, Sile S, Gainer JV, Yu C, Nadeau J, Adam A, Brown NJ. Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema. Hypertension. 2008 Jan; 51(1):141-7. PMID: 18025295.
      View in: PubMed
    47. Byrd JB, Shreevatsa A, Putlur P, Foretia D, McAlexander L, Sinha T, Does MD, Brown NJ. Dipeptidyl peptidase IV deficiency increases susceptibility to angiotensin-converting enzyme inhibitor-induced peritracheal edema. J Allergy Clin Immunol. 2007 Aug; 120(2):403-8. PMID: 17531305.
      View in: PubMed
    48. Byrd JB, Adam A, Brown NJ. Angiotensin-converting enzyme inhibitor-associated angioedema. Immunol Allergy Clin North Am. 2006 Nov; 26(4):725-37. PMID: 17085287.
      View in: PubMed
    49. Holt PR, Bresalier RS, Ma CK, Liu KF, Lipkin M, Byrd JC, Yang K. Calcium plus vitamin D alters preneoplastic features of colorectal adenomas and rectal mucosa. Cancer. 2006 Jan 15; 106(2):287-96. PMID: 16353199.
      View in: PubMed
    50. Mazurek N, Sun YJ, Price JE, Ramdas L, Schober W, Nangia-Makker P, Byrd JC, Raz A, Bresalier RS. Phosphorylation of galectin-3 contributes to malignant transformation of human epithelial cells via modulation of unique sets of genes. Cancer Res. 2005 Dec 01; 65(23):10767-75. PMID: 16322222.
      View in: PubMed
    51. Song S, Byrd JC, Mazurek N, Liu K, Koo JS, Bresalier RS. Galectin-3 modulates MUC2 mucin expression in human colon cancer cells at the level of transcription via AP-1 activation. Gastroenterology. 2005 Nov; 129(5):1581-91. PMID: 16285957.
      View in: PubMed
    52. Song S, Byrd JC, Koo JS, Bresalier RS. Bile acids induce MUC2 overexpression in human colon carcinoma cells. Cancer. 2005 Apr 15; 103(8):1606-14. PMID: 15754327.
      View in: PubMed
    53. Bresalier RS, Byrd JC, Tessler D, Lebel J, Koomen J, Hawke D, Half E, Liu KF, Mazurek N. A circulating ligand for galectin-3 is a haptoglobin-related glycoprotein elevated in individuals with colon cancer. Gastroenterology. 2004 Sep; 127(3):741-8. PMID: 15362030.
      View in: PubMed
    54. Byrd JC, Bresalier RS. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev. 2004 Jan-Jun; 23(1-2):77-99. PMID: 15000151.
      View in: PubMed
    55. Sternberg LR, Byrd JC, Hansson GC, Liu KF, Bresalier RS. Alternative splicing of the human MUC2 gene. Arch Biochem Biophys. 2004 Jan 01; 421(1):21-33. PMID: 14678781.
      View in: PubMed
    56. Dudas SP, Yunker CK, Sternberg LR, Byrd JC, Bresalier RS. Expression of human intestinal mucin is modulated by the beta-galactoside binding protein galectin-3 in colon cancer. Gastroenterology. 2002 Sep; 123(3):817-26. PMID: 12198708.
      View in: PubMed
    57. Mazurek N, Conklin J, Byrd JC, Raz A, Bresalier RS. Phosphorylation of the beta-galactoside-binding protein galectin-3 modulates binding to its ligands. J Biol Chem. 2000 Nov 17; 275(46):36311-5. PMID: 10961987.
      View in: PubMed
    58. Byrd JC, Yunker CK, Xu QS, Sternberg LR, Bresalier RS. Inhibition of gastric mucin synthesis by Helicobacter pylori. Gastroenterology. 2000 Jun; 118(6):1072-9. PMID: 10833482.
      View in: PubMed
    59. Sternberg LR, Byrd JC, Yunker CK, Dudas S, Hoon VK, Bresalier RS. Liver colonization by human colon cancer cells is reduced by antisense inhibition of MUC2 mucin synthesis. Gastroenterology. 1999 Feb; 116(2):363-71. PMID: 9922317.
      View in: PubMed
    60. Bresalier RS, Mazurek N, Sternberg LR, Byrd JC, Yunker CK, Nangia-Makker P, Raz A. Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3. Gastroenterology. 1998 Aug; 115(2):287-96. PMID: 9679034.
      View in: PubMed
    61. Bresalier RS, Byrd JC, Brodt P, Ogata S, Itzkowitz SH, Yunker CK. Liver metastasis and adhesion to the sinusoidal endothelium by human colon cancer cells is related to mucin carbohydrate chain length. Int J Cancer. 1998 May 18; 76(4):556-62. PMID: 9590134.
      View in: PubMed
    62. Capon C, Wieruszeski JM, Lemoine J, Byrd JC, Leffler H, Kim YS. Sulfated lewis X determinants as a major structural motif in glycans from LS174T-HM7 human colon carcinoma mucin. J Biol Chem. 1997 Dec 19; 272(51):31957-68. PMID: 9405387.
      View in: PubMed
    63. Bresalier RS, Yan PS, Byrd JC, Lotan R, Raz A. Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system. Cancer. 1997 Aug 15; 80(4):776-87. PMID: 9264362.
      View in: PubMed
    64. Byrd JC, Yan P, Sternberg L, Yunker CK, Scheiman JM, Bresalier RS. Aberrant expression of gland-type gastric mucin in the surface epithelium of Helicobacter pylori-infected patients. Gastroenterology. 1997 Aug; 113(2):455-64. PMID: 9247464.
      View in: PubMed
    65. Bresalier RS, Byrd JC, Wang L, Raz A. Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3. Cancer Res. 1996 Oct 01; 56(19):4354-7. PMID: 8813123.
      View in: PubMed
    66. Bresalier RS, Ho SB, Schoeppner HL, Kim YS, Sleisenger MH, Brodt P, Byrd JC. Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis. Gastroenterology. 1996 May; 110(5):1354-67. PMID: 8613039.
      View in: PubMed
    67. Byrd JC, Dahiya R, Huang J, Kim YS. Inhibition of mucin synthesis by benzyl-alpha-GalNAc in KATO III gastric cancer and Caco-2 colon cancer cells. Eur J Cancer. 1995; 31A(9):1498-505. PMID: 7577079.
      View in: PubMed
    68. Yang JM, Byrd JC, Siddiki BB, Chung YS, Okuno M, Sowa M, Kim YS, Matta KL, Brockhausen I. Alterations of O-glycan biosynthesis in human colon cancer tissues. Glycobiology. 1994 Dec; 4(6):873-84. PMID: 7734850.
      View in: PubMed
    69. Ohara S, Byrd JC, Gum JR, Kim YS. Biosynthesis of two distinct types of mucin in HM3 human colon cancer cells. Biochem J. 1994 Feb 01; 297 ( Pt 3):509-16. PMID: 8110187.
      View in: PubMed
    70. Siddiki B, Ho JJ, Huang J, Byrd JC, Lau E, Yuan M, Kim YS. Monoclonal antibody directed against colon cancer mucin has high specificity for malignancy. Int J Cancer. 1993 May 28; 54(3):467-74. PMID: 7685327.
      View in: PubMed
    71. Toribara NW, Roberton AM, Ho SB, Kuo WL, Gum E, Hicks JW, Gum JR, Byrd JC, Siddiki B, Kim YS. Human gastric mucin. Identification of a unique species by expression cloning. J Biol Chem. 1993 Mar 15; 268(8):5879-85. PMID: 7680650.
      View in: PubMed
    72. Dahiya R, Kwak KS, Byrd JC, Ho S, Yoon WH, Kim YS. Mucin synthesis and secretion in various human epithelial cancer cell lines that express the MUC-1 mucin gene. Cancer Res. 1993 Mar 15; 53(6):1437-43. PMID: 8443822.
      View in: PubMed
    73. Dahiya R, Itzkowitz SH, Byrd JC, Kim YS. Mucin oligosaccharide biosynthesis in human colonic cancerous tissues and cell lines. Cancer. 1992 Sep 15; 70(6):1467-76. PMID: 1515998.
      View in: PubMed
    74. Dahiya R, Lesuffleur T, Kwak KS, Byrd JC, Barbat A, Zweibaum A, Kim YS. Expression and characterization of mucins associated with the resistance to methotrexate of human colonic adenocarcinoma cell line HT29. Cancer Res. 1992 Sep 01; 52(17):4655-62. PMID: 1511431.
      View in: PubMed
    75. Huang J, Byrd JC, Siddiki B, Yuan M, Lau E, Kim YS. Monoclonal antibodies against partially deglycosylated colon cancer mucin that recognize Tn antigen. Dis Markers. 1992 Mar-Apr; 10(2):81-94. PMID: 1281060.
      View in: PubMed
    76. Niv Y, Byrd JC, Ho SB, Dahiya R, Kim YS. Mucin synthesis and secretion in relation to spontaneous differentiation of colon cancer cells in vitro. Int J Cancer. 1992 Jan 02; 50(1):147-52. PMID: 1728605.
      View in: PubMed
    77. Huang J, Byrd JC, Yoon WH, Kim YS. Effect of benzyl-alpha-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells. Oncol Res. 1992; 4(11-12):507-15. PMID: 1284381.
      View in: PubMed
    78. Gum JR, Hicks JW, Lagace RE, Byrd JC, Toribara NW, Siddiki B, Fearney FJ, Lamport DT, Kim YS. Molecular cloning of rat intestinal mucin. Lack of conservation between mammalian species. J Biol Chem. 1991 Nov 25; 266(33):22733-8. PMID: 1939280.
      View in: PubMed
    79. Rafiee P, Leffler H, Byrd JC, Cassels FJ, Boedeker EC, Kim YS. A sialoglycoprotein complex linked to the microvillus cytoskeleton acts as a receptor for pilus (AF/R1) mediated adhesion of enteropathogenic Escherichia coli (RDEC-1) in rabbit small intestine. J Cell Biol. 1991 Nov; 115(4):1021-9. PMID: 1683351.
      View in: PubMed
    80. Kim YS, Gum JR, Byrd JC, Toribara NW. The structure of human intestinal apomucins. Am Rev Respir Dis. 1991 Sep; 144(3 Pt 2):S10-4. PMID: 1892319.
      View in: PubMed
    81. Yonezawa S, Byrd JC, Dahiya R, Ho JJ, Gum JR, Griffiths B, Swallow DM, Kim YS. Differential mucin gene expression in human pancreatic and colon cancer cells. Biochem J. 1991 Jun 15; 276 ( Pt 3):599-605. PMID: 2064602.
      View in: PubMed
    82. Byrd JC, Ho JJ, Lamport DT, Ho SB, Siddiki B, Huang J, Yan PS, Kim YS. Relationship of pancreatic cancer apomucin to mammary and intestinal apomucins. Cancer Res. 1991 Feb 01; 51(3):1026-33. PMID: 1988113.
      View in: PubMed
    83. Yan PS, Ho SB, Itzkowitz SH, Byrd JC, Siddiqui B, Kim YS. Expression of native and deglycosylated colon cancer mucin antigens in normal and malignant epithelial tissues. Lab Invest. 1990 Nov; 63(5):698-706. PMID: 2232715.
      View in: PubMed
    84. Gum JR, Hicks JW, Swallow DM, Lagace RL, Byrd JC, Lamport DT, Siddiki B, Kim YS. Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. Biochem Biophys Res Commun. 1990 Aug 31; 171(1):407-15. PMID: 2393399.
      View in: PubMed
    85. Itzkowitz SH, Dahiya R, Byrd JC, Kim YS. Blood group antigen synthesis and degradation in normal and cancerous colonic tissues. Gastroenterology. 1990 Aug; 99(2):431-42. PMID: 2114334.
      View in: PubMed
    86. Kuan SF, Byrd JC, Basbaum C, Kim YS. Inhibition of mucin glycosylation by aryl-N-acetyl-alpha-galactosaminides in human colon cancer cells. J Biol Chem. 1989 Nov 15; 264(32):19271-7. PMID: 2509474.
      View in: PubMed
    87. Dahiya R, Itzkowitz SH, Byrd JC, Kim YS. ABH blood group antigen expression, synthesis, and degradation in human colonic adenocarcinoma cell lines. Cancer Res. 1989 Aug 15; 49(16):4550-6. PMID: 2545345.
      View in: PubMed
    88. Byrd JC, Lamport DT, Siddiqui B, Kuan SF, Erickson R, Itzkowitz SH, Kim YS. Deglycosylation of mucin from LS174T colon cancer cells by hydrogen fluoride treatment. Biochem J. 1989 Jul 15; 261(2):617-25. PMID: 2775237.
      View in: PubMed
    89. Gum JR, Byrd JC, Hicks JW, Toribara NW, Lamport DT, Kim YS. Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphism. J Biol Chem. 1989 Apr 15; 264(11):6480-7. PMID: 2703501.
      View in: PubMed
    90. Siddiqui B, Byrd JC, Fearney FJ, Kim YS. Comparison of metabolically labeled mucins of LS174T human colon cancer cells in tissue culture and xenograft. Tumour Biol. 1989; 10(2):83-94. PMID: 2734549.
      View in: PubMed
    91. Byrd JC, Nardelli J, Siddiqui B, Kim YS. Isolation and characterization of colon cancer mucin from xenografts of LS174T cells. Cancer Res. 1988 Dec 01; 48(23):6678-85. PMID: 3180078.
      View in: PubMed
    92. Ho JJ, Chung YS, Fujimoto Y, Bi N, Ryan W, Yuan SZ, Byrd JC, Kim YS. Mucin-like antigens in a human pancreatic cancer cell line identified by murine monoclonal antibodies SPan-1 and YPan-1. Cancer Res. 1988 Jul 15; 48(14):3924-31. PMID: 2454732.
      View in: PubMed
    93. Webb JW, Jiang K, Gillece-Castro BL, Tarentino AL, Plummer TH, Byrd JC, Fisher SJ, Burlingame AL. Structural characterization of intact, branched oligosaccharides by high performance liquid chromatography and liquid secondary ion mass spectrometry. Anal Biochem. 1988 Mar; 169(2):337-49. PMID: 3132867.
      View in: PubMed
    94. Kuan SF, Byrd JC, Basbaum CB, Kim YS. Characterization of quantitative mucin variants from a human colon cancer cell line. Cancer Res. 1987 Nov 01; 47(21):5715-24. PMID: 3664476.
      View in: PubMed
    95. Gum JR, Kam WK, Byrd JC, Hicks JW, Sleisenger MH, Kim YS. Effects of sodium butyrate on human colonic adenocarcinoma cells. Induction of placental-like alkaline phosphatase. J Biol Chem. 1987 Jan 25; 262(3):1092-7. PMID: 3805014.
      View in: PubMed
    96. Boland CR, Roberts JA, Siddiqui B, Byrd J, Kim YS. Cancer-associated colonic mucin in cultured human tumor cells and athymic (nude) mouse xenografts. Cancer Res. 1986 Nov; 46(11):5724-9. PMID: 3756919.
      View in: PubMed
    97. Byrd JC, Fearney FJ, Kim YS. Rat intestinal nucleotide-sugar pyrophosphatase. Localization, partial purification, and substrate specificity. J Biol Chem. 1985 Jun 25; 260(12):7474-80. PMID: 2987256.
      View in: PubMed
    98. Kim YS, Byrd JC. Ulcerative colitis: a specific mucin defect? Gastroenterology. 1984 Nov; 87(5):1193-5. PMID: 6479541.
      View in: PubMed
    99. Byrd JC, Tarentino AL, Maley F, Atkinson PH, Trimble RB. Glycoprotein synthesis in yeast. Identification of Man8GlcNAc2 as an essential intermediate in oligosaccharide processing. J Biol Chem. 1982 Dec 25; 257(24):14657-66. PMID: 6757247.
      View in: PubMed
    100. Byrd JC, Touster O. Isolation and partial characterization of the oligosaccharide moieties of rat preputial beta-glucuronidase. Biochim Biophys Acta. 1981 Sep 18; 677(1):69-78. PMID: 7295790.
      View in: PubMed
    101. Trimble RB, Byrd JC, Maley F. Effect of glucosylation of lipid intermediates on oligosaccharide transfer in solubilized microsomes from Saccharomyces cerevisiae. J Biol Chem. 1980 Dec 25; 255(24):11892-5. PMID: 7002929.
      View in: PubMed
    102. Kanfer JN, Mumford RA, Raghavan SS, Byrd J. Purification of beta-glucosidase activities from bovine spleen by affinity chromatography. Anal Biochem. 1974 Jul; 60(1):200-5. PMID: 4853973.
      View in: PubMed
    103. Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells. Breast Cancer Research. 18.
    104. Alterations in gastric mucin synthesis by Helicobacter pylori. World Journal of Gastroenterology. 6:475-482.
    105. Post-translational modification of galectin-3 and its role in biological function. 137-151.
    106. Inclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinoma. BMC Clinical Pathology. 6.
    107. Galectin-3 in the Progression and Metastasis of Colorectal Neoplasia. 193-221.
    BYRD's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description